טוען...
Keishibukuryogan is not carcinogenic in Sprague-Dawley rats
Keishibukuryogan is a traditional Japanese medicine widely administered to patients with menopausal symptoms. Because humans use it on a long-term basis, we believed that a carcinogenicity study was warranted. We orally administered keishibukuryogan (TJ-25) extract powder to 6-week-old Sprague-Dawle...
שמור ב:
| הוצא לאור ב: | J Toxicol Pathol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Japanese Society of Toxicologic Pathology
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4866007/ https://ncbi.nlm.nih.gov/pubmed/27182114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1293/tox.2015-0017 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|